What is Bioanalysis?
What is Bioanalysis?
Bioanalysis is a specialized branch of analytical chemistry that aims to quantify the concentration of a drug, metabolite, or biomarker in a biological matrix such as blood, serum, plasma, urine, or tissue samples.
For small molecules drugs, method development involves selecting an appropriate sample preparation technique to isolate the drug or metabolite of interest from the biological matrix.
For Biologics, the bioanalytical assays must be highly selective to avoid cross-reactivity with endogenous substances or other analytes in the sample matrix. We use an array of strategies starting from Ligand binding assays (LBAs) such as ELISA, LC-MS/MS, LC-HRMS, and hybrid LC-MS or immunoaffinity-LC-MS.
When Are Bioanalytical Studies Needed in Drug Development?
Bioanalytical studies are critical in any drug discovery and development program. Studies that require bioanalytical support include bioavailability (BA)/bioequivalence (BE), non-clinical pharmacokinetics (PK)/toxicokinetics (TK), anti-drug antibody assays (ADA), and biomarker evaluation. Guidelines for these studies have been outlined by the FDA, ICH, EMA, and other global regulatory bodies.
Emery Pharma Can Help
with Your Discovery and Development Programs
Reliable bioanalytical assays require robust method development and validation. At Emery Pharma, we utilize sophisticated techniques to help our Clients’ with their bioanalysis needs in support of all stages of drug discovery and development programs.
Maximize potency for lead molecule, identify critical drug metabolites, evaluate pharmacokinetic parameters, and minimize toxicity through drug-drug-interactions (DDI) with state-of-the-art instrumentation.
Ligand Binding Assays
Expertise in Bioanalysis for Biopharmaceuticals via Ligand Binding Assays (LBAs) such as ELISA for applications in Serum Drug Concentration (SDC), Anti-drug antibody (ADA), and Neutralizing antibody (NAb) assays, and more.
What Are the Challenges in Bioanalysis?
For many scientists, bioanalytical method development, validation, and reporting may seem like a ‘black box’ – as it necessitates an intuitive understanding of how analytes behave in an ever-evolving complex biological matrix. Utilizing a customized approach, our team has the experience to face every challenge that comes our way. We are perfectly suited to handle all of the following challenging aspects about Bioanalysis.
We are happy to be the partnering lab for Clients requiring analysis for such hard-to-solve problems by sharing our extensive technical knowledge and experience. Please contact us today to learn more about our services and let us know how we can be your bridge to success on your next bioanalysis project.
Requirement for robust methods that work with many different sample types and background matrices, such as blood/plasma/serum, various tissues, and samples from both pre-clinical and clinical setting.
Processing Unpredictable Samples
Processing samples derived from unknown genetic, metabolic, and dietary makeup, which pose unpredictability during analysis.
Employing sophisticated instrumentation such as triple quadrupole mass spectrometers that require specialized training.
Adherence to GLP Guidelines
Submissions with phase-appropriately validated methods that adhere to GLP guidelines described in 21CFR58, Good Laboratory Practice for Nonclinical Laboratory Studies.
Familiarity with Industry Standards
Familiarity with Regional differences in guidance and acceptance standards for various regulatory bodies (FDA in the United States, EMA in Europe, ANVISA in Brazil, etc.) that are updated regularly.